H.C. Wainwright analyst Andres Maldonado reiterated a Buy rating and $9.00 price target on NovaBridge Biosciences (NASDAQ: NBP).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments